## Core Concept
Amifostine is a cytoprotective agent used primarily to reduce the incidence of neutropenia-related fever and infection induced by chemotherapy and to decrease the cumulative toxicity of platinum-based chemotherapy on the kidneys. It works by protecting normal tissues from the damage caused by reactive oxygen species.

## Why the Correct Answer is Right
Amifostine exerts its protective effects mainly through its active metabolite, WR-1065, which acts as a free radical scavenger. This mechanism helps protect normal tissues, such as the bone marrow, kidneys, and nerves, from damage caused by chemotherapy and radiation. However, amifostine's protective effects are not uniform across all tissues or types of damage.

## Why Each Wrong Option is Incorrect
- **Option A:** Amifostine is known to protect against nephrotoxicity caused by cisplatin, a common chemotherapy agent. Therefore, this option is incorrect as amifostine does offer protection.
- **Option B:** It provides protection against ototoxicity, particularly in the context of cisplatin and radiation therapy. So, this option is incorrect.
- **Option C:** Amifostine can reduce the incidence of neutropenia-related fever and infection, indicating its protective effect on the bone marrow. This makes the option incorrect.

## Why Option D is Correct
- **Option D:** Amifostine does not significantly protect the gastrointestinal system from the toxic effects of chemotherapy in the same way it protects other organs like the kidneys or bone marrow. Its protective effects are more pronounced in reducing nephrotoxicity, neurotoxicity, and ototoxicity.

## Clinical Pearl / High-Yield Fact
A key point to remember is that amifostine's protective effects are most notable in reducing nephrotoxicity from cisplatin and in decreasing the incidence of severe infections in patients undergoing chemotherapy. However, its use can be limited by side effects such as nausea and hypotension.

## Correct Answer: D. gastrointestinal toxicity.